Back
Bone Biologics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
BBLG
Bone Biologics
Last Price:
1.28
Seasonality Move:
-17.7%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Bone Biologics Stock Forecast
-
Is Bone Biologics Stock Undervalued?
The current Bone Biologics [BBLG] share price is $1.25. The Score for BBLG is 7, which is 86% below its historic median score of 50, and infers higher risk than normal. - BBLG is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Bone Biologics Stock Go Up Next Year?
Data Unavailable
Bone Biologics Stock Rating
Data Unavailable
Bone Biologics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bonebiologics.com
52-Week Data
52-Week High:
10.56
52-Week Low:
0.80
Prediction Charts
Market Cap:
3.08M
Price in USD:
1.25
Volume:
32.8K
Beta:
0.45
Technical Analysis
SMA50:
1.64
SMA100:
1.57
SMA200:
1.80
52-Wk Change:
-67.85%
Stock Predictions
-
Is Bone Biologics stock public?
Yes, Bone Biologics is a publicly traded company. -
What is the Bone Biologics stock quote today?
The Bone Biologics stock price is 1.25 USD today. -
How to buy Bone Biologics stock online?
You can buy Bone Biologics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-5 | 1.34 | 1.39 | 1.41 | 1.31 |
| Nov-6 | 1.39 | 1.28 | 1.40 | 1.25 |
| Nov-7 | 1.29 | 1.30 | 1.34 | 1.26 |
| Nov-8 | 1.30 | 1.36 | 1.38 | 1.30 |
| Nov-11 | 1.34 | 1.32 | 1.36 | 1.30 |
| Nov-12 | 1.27 | 1.20 | 1.35 | 1.20 |
| Nov-13 | 1.20 | 1.18 | 1.21 | 1.14 |
| Nov-14 | 1.18 | 1.29 | 1.39 | 1.15 |
| Nov-15 | 1.30 | 1.19 | 1.32 | 1.14 |
| Nov-18 | 1.19 | 1.19 | 1.22 | 1.17 |
| Nov-19 | 1.19 | 1.32 | 1.38 | 1.19 |
| Nov-20 | 1.29 | 1.26 | 1.32 | 1.25 |
| Nov-21 | 1.27 | 1.23 | 1.29 | 1.21 |
| Nov-22 | 1.22 | 1.25 | 1.29 | 1.22 |
Bone Biologics Earnings
Data Unavailable
Bone Biologics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.77 per share, and an increase next year of $3.05 per share.
* Bone Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.